Neovasc Inc. | Income Statement

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
11,747.60
15,863.50
12,704.10
12,603.70
6,995.00
2,267.10
Cost of Goods Sold (COGS) incl. D&A
7,281.90
10,352.80
9,308.70
10,119.60
5,131.40
972.60
Gross Income
4,465.70
5,510.60
3,395.40
2,484.10
1,863.60
1,294.50
SG&A Expense
11,574.70
24,677.10
31,158.00
33,822.20
40,464.60
35,044.70
EBIT
7,109.00
19,166.40
27,762.60
31,338.10
38,601.00
33,750.20
Unusual Expense
-
-
9,030.10
165,550.60
9,843.70
9,392
Non Operating Income/Expense
356.40
106.50
2,073.50
82,319.90
3,539.30
36,214
Interest Expense
9.20
7.70
3.20
-
4,350.90
60,781.80
Pretax Income
6,750.30
19,061.10
33,984.20
114,333.30
29,107.00
139,900.70
Income Tax
-
-
214.10
265.70
628.80
138.80
Consolidated Net Income
6,750.30
19,061.10
34,198.30
114,599.00
29,735.80
140,039.60
Net Income
6,750.30
19,061.10
34,198.30
114,599.00
29,735.80
140,039.60
Net Income After Extraordinaries
6,750.30
19,061.10
34,198.30
114,599.00
29,735.80
140,039.60
Net Income Available to Common
6,750.30
19,061.10
34,198.30
114,599.00
29,735.80
140,039.60
EPS (Basic)
0.14
0.36
0.52
1.70
0.36
98.90
Basic Shares Outstanding
47,361.30
52,289.50
65,397.10
67,465.30
81,523.90
1,416
EPS (Diluted)
0.14
0.36
0.52
1.70
0.36
98.90
Diluted Shares Outstanding
47,361.30
52,289.50
65,397.10
67,465.30
81,523.90
1,416
EBITDA
6,837.30
18,790.60
27,118.20
30,336.80
37,907.10
33,252.30
Non-Operating Interest Income
11.50
219.50
738.20
235.50
461.80
237.30

About Neovasc

View Profile
Address
13562 Maycrest Way
Richmond British Columbia V6V 2J7
Canada
Employees -
Website http://www.neovasc.com
Updated 07/08/2019
Neovasc, Inc. engages in the development, manufacture, and marketing of medical devices for the cardiovascular marketplace. Its products includes Neovast Tiara and Neovasc Reducer. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.